Abstract:Objective To explore the predictive value of plasma antithrombin Ⅲ and fibrinogen in patients with non-ST segment-elevation acute coronary syndrome (NSTE-ACS). Methods Totally 280 patients diagnosed with NSTE-ACS admitted into the hospital from January 2015 to December 2016 were involved. Forty healthy subjects were regarded as control group. Patients in NSTE-ACS group were further divided into low risk group (score ≤ 108, 47 cases), moderate risk group (109 ≤ score ≤ 140, 106 cases) and high risk group (score > 106, 127 cases) according to GRACE score. Levels of plasma AT- Ⅲ and FIB were measured. Correlation analysis were performed between AT- Ⅲ , FIB level and GRACE score. Multi-factor linear regression was conducted to identify independent predictive factors of GRACE score. ROC curve analysis was utilized to evaluate the significance of AT- Ⅲ and FIB in NSTE-ACS patients. Logistic multivariate regression analysis was performed to find independent predictive factors of NSTE-ACS. Results Compared with the control group, levels of AT-Ⅲ decreased while FIB increased significantly in experimental group (P < 0.05). GRACE score was negatively correlated with AT-Ⅲ (r = -0.494, P < 0.05) while positively correlated with FIB level (r = 0.513, P < 0.05). AT-Ⅲand FIB are independent predictive factors of GRACE score (P < 0.05). The ROC curve analysis showed that the AUC for AT-Ⅲ and FIB were 0.797 and 0.756, respectively (P < 0.05). Cut-off point was 85.50 and 4.03 for AT-Ⅲand FIB, respectively. Sensitivity for AT-Ⅲand FIB were 69%, 66% and the specificity were 91%, 93%, respectively. Conclusions Plasma AT-Ⅲand FIB are both independent predictive factors in evaluating risk stratification for high risk of NSTE-ACS.